Basic pharmacology relevant to drug abuse assessment: Tramadol as example

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 2, 2008, Pages 101-108

  Raffa, R B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Abuse potential; Tramadol

Indexed keywords

MORPHINE; NALOXONE; QUINIDINE; TRAMADOL;

ANALGESIC ACTIVITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; DRUG ABUSE; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; HUMAN; NONHUMAN; REVIEW; SEIZURE;

ANALGESICS, OPIOID; ANIMALS; BRAIN; CYTOCHROME P-450 CYP2D6; HUMANS; NARCOTICS; SUBSTANCE-RELATED DISORDERS; TRAMADOL;

EID: 40349087012     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00897.x     Document Type: Review

References (56)

1. Hennies HH, Friderichs E, Schneider J (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung, 38, 877 880.
2. Driessen B, Reimann W (1989) Effects of tramadol on noradrenaline release from rat brain cortex slices. Naunyn-Schmiedebergs Archives of Pharmacology, 339 (Suppl. R89.
3. Reimann W, Driessen B, Schlütz H (1990) Does a non-opioid component contribute to the efficacy of the central analgesic tramadol? 10th European Winter Conference on Brain Research, March 3-10, 1990.
4. Friderichs E, Reimann W, Selve N (1991) Investigations on opioid and non-opioid components in tramadol antinociception. Naunyn-Schmiedebergs Archives of Pharmacology, 344 (Suppl. 1 R72.
5. Driessen B, Reimann W (1992) Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. British Journal of Pharmacology, 105, 147 151.
6. Friderichs E, Reimann W, Selve N (1992) Contribution of both enantiomers to antinociception of the centrally acting analgesic tramadol. Naunyn-Schmiedebergs Archives of Pharmacology, 346, R36.
7. Kayser V, Besson JM, Guilbaud G (1992) Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. European Journal of Pharmacology, 224, 83 88.
8. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics, 260, 275 285.
9. Collart L, Luthy C, Dayer P (1993) Partial inhibition of tramadol antinociceptive effect by naloxone in man. British Journal of Clinical Pharmacology, 35, 73P.
10. Collart L, Luthy C, Dayer P (1993) Multimodal analgesic effect of tramadol. Clinical Pharmacology and Therapeutics, 53, 223.
11. Driessen B, Reimann W, Giertz H (1993) Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. British Journal of Pharmacology, 108, 806 811.
12. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N (1993) Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. Journal of Pharmacology and Experimental Therapeutics, 267, 331 340.
13. Sevcik J, Nieber K, Driessen B, Illes P (1993) Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus cœruleus neurons. British Journal of Pharmacology, 110, 169 176.
14. Desmeules J, Piguet V, Collart L, Dayer P (1994) Yohimbine antagonism as a tool to assess the extent of monoaminergic modulation in analgesics effects - experience with tramadol. Experientia, 50, A79.
15. Desmeules J, Piguet V, Collart L, Dayer P (1994) Contributions of monoaminergic modulation in tramadol analgesics effect. Clinical Pharmacology and Therapeutics, 55, 151.
16. Reimann W, Hennies HH (1994) Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol. Biochemical Pharmacology, 47, 2289 2293.
17. Desmeules J, Piguet V, Collart L, Dayer P (1996) Contribution of monoaminergic modulation to the analgesic effect of tramadol. British Journal of Pharmacology, 41, 7 12.
18. 1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Psychopharmacology, 188, 111 118.
19. Ide S, Minami M, Ishihara K, Uhl GR, Sora I, Ikeda K (2006) Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology, 51, 651 658.
20. Oliva P, Aurilio C, Massimo F, Grella A, Maione S, Grella E, Scafuro M, Rossi F, Berrino L (2002) The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. European Journal of Pharmacology, 445, 179 185.
21. Preston KL, Jasinski DR, Testa M (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug and Alcohol Dependence, 27, 7 17.
22. Epstein DH, Preston KL, Jasinski DR (2006) Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biological Psychiatry, 73, 90 99.
23. Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Munoz A (2005) Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiology and Drug Safety, 14, 851 859.
24. Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE (2006) A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. Journal of Pain and Symptom Management, 31, 465 476.
25. American Psychiatric Association (2000) DSM-IV-TR™, 4th edn. Arlington, VA : American Psychiatric Association.
26. Anonymous, McDiarmid T, Mackler L, Schneider DM (2005) What is the addiction risk associated with tramadol? Journal of Family Practice, 54, 72 74.
27. Gillen C, Haurand M, Kobelt DJ, Wnendt S (2000) Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor. Naunyn-Schmiedebergs Archives of Pharmacology, 362, 116 121.
28. Lintz W, Erlacin S, Frankus E, Uragg H (1981) Biotransformation of tramadol in man and animal (author's transl). Arzneimittelforschung, 31, 1932 1943.
29. Paar WD, Frankus P, Dengler HJ (1992) The metabolism of tramadol by human liver microsomes. The Clinical Investigator, 70, 708 710.
30. Wu WN, McKown LA, Liao S (2002) Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica, 32, 411 425.
31. Millan MJ (2002) Descending control of pain. Progress in Neurobiology, 66, 355 474.
32. Friderichs E, Felgenhauer F, Jongschaapp P, Osterloh G (1978) Pharmacological studies on analgesia, dependence on and tolerance of tramadol, a potent analgetic drug. Arzneimittel Forschung, 28, 122 134.
33. Flohé L, Arend I, Cogal A, Richter W, Simon W (1978) Klinische prüfung der abhängigkeitsentwicklung nach langzeitapplikation von tramadol. Arzneimittelforschung, 28, 213 217.
34. Richter W, Flohé L, Giertz H (1980) Clinical evaluation of dependence-liability of tramadol. Naunyn-Schmiedebergs Archives of Pharmacology, 313 (Suppl. R62.
35. Bitsch M, Emmrich J, Hary J, Lippach G, Rindt W (1980) Geburtshilfliche analgesie mit tramadol. Fortschritte der Medizin, 16, 632 634.
36. Rettig G, Kropp J (1980a) Analgetische Wirkung von tramadol beim akuten Myocardinfarkt. Therapie der Gegenwart, 119, 705 707.
37. Rettig G, Kropp J (1980b) Analgetische Wirkung von tramadol beim akuten Myocardinfarkt. Die Therapiewoche, 30, 5561 5566.
38. Budd K (1990) The dose response curve for tramadol hydrochloride in man. Pain, 43 (Suppl. 5 S268.
39. Bono AV, Cuffari S (1993) Analgesic activity and safety of tramadol in neoplastic pain: a controlled study vs buprenorphine. Abstracts - 7th World Congress on Pain. Seattle, WA : IASP Publications, 333 334.
40. Meszaros I, Borsi M, Kremer I, Boros J, Palast I, Danczig A (1993) Pain relief with tramadol (Tramal) after abdominal and thoracic surgery. Abstracts - 7th World Congress on Pain. Seattle, WA : IASP Publications, 136 137.
41. de la Torre MR, Rodriguez MJ, Perez P, Torres LM, Pallares J (1993) Postoperative pain relief: a comparative trial tramadol vs NSAIDs in intravenous infusion. Abstracts - 7th World Congress on Pain. Seattle, WA : IASP Publications, P 59.
42. Lehmann KA, Kratzenberg U, Schroeder-Bark B, Horrichs-Haermeyer G (1990) Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clinical Journal of Pain, 6, 212 220.
43. Kayser V, Besson JM, Guilbaud G (1991) Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine. European Journal of Pharmacology, 1195, 37 45.
44. Paar WD, Poche S, Gerloff J, Dengler HJ (1997) Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. European Journal of Clinical Pharmacology, 53, 235 239.
45. Poulsen L, Arendt-Nielsen L, Brosen K, Sindrup SH (1996) The hypoalgesic effect of tramadol in relation to CYP2D6. Clinical Pharmacology and Therapeutics, 60, 636 644.
46. Stamer UM, Lehnen K, Höthker F, Bayerer B, Wolf S, Hoeft A, Stuber F (2003) Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain, 105, 231 238.
47. Wang GX, Zhang H, He FF, Fang XM (2006) Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population. European Journal of Clinical Pharmacology, 62, 927 931.
48. Stamer UM, Musshoff F, Kobilay M, Madea B, Hoeft A, Stuber F (2007) Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clinical Pharmacology and Therapeutics, 82, 41 47.
49. Tallarida RJ (2000) Drug synergism and dose-response data. Boca Raton, FL : Chapman & Hall/CRC Press.
50. Quetglas EG, Azanza JR, Cardenas E, Sádaba B, Campanero MA (2007) Stereoselective pharmacokinetic analysis of tramadol and its main Phase I metabolites in healthy subjects after intravenous and oral administration or racemic tramadol. Biopharmaceutics and Drug Disposition, 28, 19 33.
51. http://www.erowid.org/experiences/exp.php?ID=14954, accessed 28 Jan 2008.
52. http://www.erowid.org/experiences/exp.php?ID=19002, accessed 28 Jan 2008.
53. http://www.usdoj.gov/dea/concern/concern.htm, accessed 28 Jan 2008.
54. Tao Q, Stone DJ Jr., Borenstein MR, Codd EE, Coogan TP, Desai-Krieger D, Liao S, Raffa RB (2002) Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally. Journal of Clinical Pharmacy and Therapeutics, 27, 99 106.
55. Gutstein HB, Akil H (2001) Opioid analgesics. In : Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics. New York, NY : McGraw-Hill, 569 619.
56. Parasrampuria R, Vuppugalla R, Elliott K, Mehvar R (2007) Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats. Chirality, 19, 190 196.